KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EPS (Basic): 2009-2024

Historic EPS (Basic) for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $0.20.

  • Charles River Laboratories International's EPS (Basic) fell 17.16% to $1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 118.88%. This contributed to the annual value of $0.20 for FY2024, which is 97.84% down from last year.
  • Charles River Laboratories International's EPS (Basic) amounted to $0.20 in FY2024, which was down 97.84% from $9.27 recorded in FY2023.
  • Charles River Laboratories International's 5-year EPS (Basic) high stood at $9.57 for FY2022, and its period low was $0.20 during FY2024.
  • Its 3-year average for EPS (Basic) is $6.35, with a median of $9.27 in 2023.
  • In the last 5 years, Charles River Laboratories International's EPS (Basic) skyrocketed by 42.17% in 2020 and then slumped by 97.84% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's EPS (Basic) stood at $7.35 in 2020, then climbed by 5.71% to $7.77 in 2021, then grew by 23.17% to $9.57 in 2022, then dropped by 3.13% to $9.27 in 2023, then plummeted by 97.84% to $0.20 in 2024.